<DOC>
	<DOCNO>NCT00001188</DOCNO>
	<brief_summary>Patients Grade II III soft tissue sarcoma extremity randomize either receive receive radiation therapy follow surgery removal local tumor . All patient protocol receive adjuvant chemotherapy .</brief_summary>
	<brief_title>The Role Multi-Modality Therapy Treatment High-Grade Soft Tissue Sarcomas Extremities</brief_title>
	<detailed_description>Patients Grade II III soft tissue sarcoma extremity randomize either receive receive radiation therapy follow surgery removal local tumor . All patient protocol receive adjuvant chemotherapy .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<criteria>Patients must biopsyproven soft tissue sarcoma one follow diagnosis : Liposarcoma ( round cell pleomorphic ) . Fibrosarcoma . Malignant fibrous histiocytoma . Inflammatory malignant fibrous histiocytoma . Myxoid malignant fibrous histiocytoma . Malignant giant cell tumor . Angiomatoid malignant fibrous histiocytoma . Leiomyosarcoma . Malignant hemangiopericytoma . Rhabdomyosarcoma ( embryonal , alveolar , pleomorphic combine ) . Soft tissue sarcoma resemble Ewing 's sarcoma . Synovial cell sarcoma . Epithelioid sarcoma . Clear cell sarcoma . Neurofibrosarcoma . Epithelioid schwannoma . Malignant triton tumor . Angiosarcoma . Mixed malignant mesenchymoma . Alvelar soft part sarcoma . Malignant granular cell tumor . All lesion must Grade II III . No patient Grade I lesion acceptable . Patients must undergo limbsparing procedure gross tumor remove . Clinical evaluation must reveal evidence metastatic disease either regional lymph node distant site . The soft tissue sarcoma must extremity either distal shoulder joint distal hip joint . The definitive surgical procedure primary lesion recurrence must perform long four month date randomization . Patients must receive prior chemotherapy radiotherapy sarcoma . Patients without history malignant disease except basal cell carcinoma . Patients serious infection , active bleeding disorder , concomitant severe disease cirrhosis , ischemic heart disease , evidence severe impairment renal function . Patients must age 30 diagnosis embryonal rhabdomyosarcoma .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Sarcoma</keyword>
	<keyword>Surgery</keyword>
</DOC>